ATRS Antares Pharma, Inc. Stock Quote

ATRS [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	12.23	EPS (ttm)	0.33	Insider Own	2.40%	Shs Outstand	166.75M	Perf Week	-2.20%
Market Cap	677.61M	Forward P/E	15.13	EPS next Y	0.27	Insider Trans	-16.50%	Shs Float	154.20M	Perf Month	-8.24%
Income	56.20M	PEG	-	EPS next Q	0.01	Inst Own	45.40%	Short Float	3.20%	Perf Quarter	-7.60%
Sales	149.60M	P/S	4.53	EPS this Y	133.30%	Inst Trans	8.96%	Short Ratio	3.95	Perf Half Y	19.88%
Book/sh	0.71	P/B	5.65	EPS next Y	85.31%	ROA	34.70%	Target Price	6.42	Perf Year	54.23%
Cash/sh	0.31	P/C	12.76	EPS next 5Y	-	ROE	76.10%	52W Range	2.39 - 5.07	Perf YTD	0.50%
Dividend	-	P/FCF	57.92	EPS past 5Y	34.10%	ROI	37.40%	52W High	-20.91%	Beta	1.50
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	26.80%	Gross Margin	57.80%	52W Low	67.78%	ATR	0.15
Employees	185	Current Ratio	2.00	Sales Q/Q	16.70%	Oper. Margin	9.10%	RSI (14)	42.41	Volatility	2.94% 3.40%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	947.50%	Profit Margin	37.60%	Rel Volume	0.58	Prev Close	4.13
Shortable	Yes	LT Debt/Eq	0.21	Earnings	Mar 02 BMO	Payout	0.00%	Avg Volume	1.25M	Price	4.01
Recom	1.50	SMA20	-2.59%	SMA50	-7.24%	SMA200	15.84%	Volume	729,750	Change	-2.91%

Oct-23-17

Reiterated

H.C. Wainwright

Buy

$5 → $3.50

Jun-23-17

Initiated

H.C. Wainwright

Buy

Apr-21-17

Initiated

Raymond James

Strong Buy

May-28-15

Initiated

Jefferies

Buy

May-18-15

Initiated

Piper Jaffray

Overweight

$3.50

Aug-08-13

Reiterated

Ladenburg Thalmann

Buy

$5 → $5.75

Jun-21-13

Resumed

Oppenheimer

Outperform

Mar-27-21 03:56AM	Antares Pharma's (NASDAQ:ATRS) Wonderful 344% Share Price Increase Shows How Capitalism Can Build Wealth Simply Wall St.
Mar-02-21 08:25AM	Antares Pharma (ATRS) Q4 Earnings Lag Estimates Zacks -9.78%
07:22AM	Recap: Antares Pharma Q4 Earnings Benzinga
07:00AM	Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results GlobeNewswire
06:30AM	Antares Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:14AM	Antares Pharma's Earnings: A Preview Benzinga +5.88%
Feb-24-21 11:51PM	Is Antares Pharma (NASDAQ:ATRS) Using Too Much Debt? Simply Wall St.
04:30PM	Antares Pharma to Present at Two Upcoming Investor Conferences GlobeNewswire
Feb-23-21 08:30AM	Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results GlobeNewswire -7.11%
Feb-17-21 08:30AM	Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference GlobeNewswire
Jan-26-21 12:02AM	Is Antares Pharma, Inc.'s(NASDAQ:ATRS) Recent Stock Performance Tethered To Its Strong Fundamentals? Simply Wall St.
Jan-11-21 08:00AM	Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million GlobeNewswire
Dec-27-20 01:12AM	What Is Antares Pharma, Inc.'s (NASDAQ:ATRS) Share Price Doing? Simply Wall St.
Dec-16-20 11:36AM	Is ATRS A Good Stock To Buy Now? Insider Monkey
Nov-30-20 11:48PM	Will the Promising Trends At Antares Pharma (NASDAQ:ATRS) Continue? Simply Wall St.
Nov-23-20 04:05PM	Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-10-20 04:30PM	Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-05-20 10:31PM	Antares Pharma Inc (ATRS) Q3 2020 Earnings Call Transcript Motley Fool
10:05AM	Antares Pharma (ATRS) Q3 Earnings Match Estimates Zacks
07:00AM	Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results GlobeNewswire
06:14AM	How Much Of Antares Pharma, Inc. (NASDAQ:ATRS) Do Insiders Own? Simply Wall St.
Oct-29-20 12:35PM	Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-22-20 08:30AM	Antares Pharma to Report Third Quarter 2020 Financial and Operating Results GlobeNewswire
Oct-12-20 06:28PM	Antares Pharma Inc (ATRS): Hedge Funds In Wait-and-See Mode Insider Monkey
Oct-06-20 07:39AM	Antares Pharma (NASDAQ:ATRS) Shareholders Have Enjoyed A 85% Share Price Gain Simply Wall St.
Oct-01-20 08:46AM	Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S. GlobeNewswire +5.19%
Sep-08-20 08:00AM	Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference GlobeNewswire
Sep-06-20 10:14AM	These 4 Measures Indicate That Antares Pharma (NASDAQ:ATRS) Is Using Debt Reasonably Well Simply Wall St.
Aug-10-20 07:00AM	Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations GlobeNewswire
Aug-07-20 09:17AM	A Quick Analysis On Antares Pharma's (NASDAQ:ATRS) CEO Compensation Simply Wall St. +7.61%
Aug-06-20 07:00AM	Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance GlobeNewswire
Aug-03-20 10:55AM	Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)? Insider Monkey +7.66%
07:00AM	Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® in Saudi Arabia and the United Arab Emirates GlobeNewswire
Jul-30-20 07:00AM	Antares Pharma to Report Second Quarter 2020 Operating and Financial Results GlobeNewswire
Jul-21-20 07:00AM	First Commercial Product Using Antares Pharmas Multi-Dose Pen Platform Launches in Europe GlobeNewswire
Jul-20-20 07:00AM	Antares Pharma Appoints Patrick Shea Senior Vice President of Commercial GlobeNewswire
Jun-24-20 09:39AM	3 Strong Buy Penny Stocks With Triple-Digit Upside Potential TipRanks
Jun-22-20 11:48AM	Hedge Funds Have Never Been This Bullish On Antares Pharma Inc (ATRS) Insider Monkey
Jun-11-20 07:00AM	Antares Pharma to Present at the Raymond James Human Health Innovation Conference GlobeNewswire -6.51%
May-28-20 07:07AM	Why Is This Fast-Growing Biotech So Undervalued? Motley Fool
May-27-20 07:00AM	Antares Pharma to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-26-20 12:36AM	Edited Transcript of ATRS earnings conference call or presentation 5-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-05-20 09:30PM	Antares Pharma Inc (ATRS) Q1 2020 Earnings Call Transcript Motley Fool -16.72%
12:24PM	Why Antares Pharma Is Crashing 12.3% Today Motley Fool
07:00AM	Antares Pharma Reports First Quarter 2020 Operating and Financial Results GlobeNewswire
Apr-28-20 07:00AM	Antares Pharma to Report First Quarter 2020 Operating and Financial Results GlobeNewswire
Mar-22-20 06:13AM	Edited Transcript of ATRS earnings conference call or presentation 3-Mar-20 1:30pm GMT Thomson Reuters StreetEvents
Mar-03-20 07:00AM	Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results GlobeNewswire
Mar-01-20 09:20AM	Health Check: How Prudently Does Antares Pharma (NASDAQ:ATRS) Use Debt? Simply Wall St.
Feb-26-20 07:00AM	Antares Pharma to Present at the Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Feb-25-20 07:00AM	Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results GlobeNewswire
Jan-27-20 07:00AM	Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million GlobeNewswire
Jan-16-20 05:59AM	Is Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Paid At A Competitive Rate? Simply Wall St.
Dec-14-19 05:20PM	Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS) Insider Monkey
Dec-10-19 07:00AM	Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development GlobeNewswire
Dec-06-19 07:00AM	Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award GlobeNewswire
Dec-02-19 09:49AM	An Intrinsic Calculation For Antares Pharma, Inc. (NASDAQ:ATRS) Suggests It's 43% Undervalued Simply Wall St.
Nov-27-19 05:51PM	Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-20-19 07:25AM	The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data Benzinga
Nov-19-19 07:00AM	REMINDER: Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire
01:00AM	Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire
Nov-13-19 07:00AM	Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire
Nov-09-19 08:03PM	Edited Transcript of ATRS earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-05-19 07:00AM	Antares Pharma Reports Third Quarter 2019 Operating and Financial Results GlobeNewswire +8.36%
Nov-01-19 11:49AM	Hedge Funds Are Selling Antares Pharma Inc (ATRS) Insider Monkey
Oct-31-19 07:00AM	Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet Needle-Free Delivery System GlobeNewswire
Oct-29-19 07:00AM	Antares Pharma to Report Third Quarter 2019 Financial and Operating Results GlobeNewswire
Oct-24-19 07:00AM	Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire
Oct-17-19 06:55AM	Do Directors Own Antares Pharma, Inc. (NASDAQ:ATRS) Shares? Simply Wall St.
Sep-17-19 07:00AM	Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire
Sep-11-19 11:50AM	Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet? Simply Wall St.
Aug-20-19 08:09AM	Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack MarketWatch
Aug-14-19 02:14PM	Edited Transcript of ATRS earnings conference call or presentation 6-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 05:23PM	Antares Pharma Inc (ATRS) Q2 2019 Earnings Call Transcript Motley Fool +10.07%
03:00PM	Loss-Making Antares Pharma, Inc. (NASDAQ:ATRS) Expected To Breakeven Simply Wall St.
07:00AM	Antares Pharma Reports Second Quarter 2019 Operating and Financial Results GlobeNewswire
Jul-30-19 07:00AM	Antares Pharma to Report Second Quarter 2019 Financial and Operating Results GlobeNewswire
Jun-27-19 07:00AM	Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital GlobeNewswire
Jun-26-19 02:08PM	Here is What Hedge Funds Think About Antares Pharma Inc (ATRS) Insider Monkey
Jun-11-19 07:00AM	Antares Pharma to Present at the Raymond James 2019 Life Sciences and MedTech Conference GlobeNewswire
Jun-06-19 11:45AM	Have Insiders Been Selling Antares Pharma, Inc. (NASDAQ:ATRS) Shares This Year? Simply Wall St.
May-30-19 07:00AM	Antares Pharma to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire
May-16-19 05:00PM	Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference GlobeNewswire
May-13-19 06:14AM	Edited Transcript of ATRS earnings conference call or presentation 2-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-09-19 02:23PM	Investors Who Bought Antares Pharma (NASDAQ:ATRS) Shares Three Years Ago Are Now Up 265% Simply Wall St.
May-02-19 01:49PM	Antares Pharma Inc (ATRS) Q1 2019 Earnings Call Transcript Motley Fool +8.76%
09:01AM	Antares Pharma: 1Q Earnings Snapshot Associated Press
07:00AM	Antares Pharma Reports First Quarter 2019 Operating and Financial Results GlobeNewswire
Apr-18-19 07:00AM	Antares Pharma to Report First Quarter 2019 Financial and Operating Results GlobeNewswire
Apr-02-19 09:43AM	Why Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Pay Matters To You Simply Wall St.
Apr-01-19 07:30AM	New Research: Key Drivers of Growth for Progress Software, Antares Pharma, National Vision, NMI, Waters, and Kelly Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-28-19 07:30AM	Antares Pharma Announces Receipt of Orphan Drug Designation for the Treatment of Ectopic Pregnancy With Methotrexate GlobeNewswire
Mar-15-19 03:43PM	Edited Transcript of ATRS earnings conference call or presentation 28-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Mar-12-19 06:48PM	Antares Pharma Inc (ATRS) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-11-19 10:35AM	AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks
Mar-06-19 07:00AM	Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference GlobeNewswire
Mar-04-19 07:00AM	Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella GlobeNewswire
Feb-28-19 12:31PM	Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM	Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results GlobeNewswire
Feb-27-19 07:00AM	Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors Conference GlobeNewswire

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and for glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto injectors; and drug/device product for urologic oncology and endocrinology. The company have strategic alliances and partnership arrangements pharmaceutical companies, including Pfizer, Idorsia, Teva, and AMAG. Antares Pharma, Inc. was founded in 1978 and is headquartered in Ewing, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GARRITY THOMAS J	Director	Mar 11	Option Exercise	1.12	50,000	56,000	274,406	Mar 12 07:04 PM
GARRITY THOMAS J	Director	Mar 11	Sale	4.28	50,000	214,000	224,406	Mar 12 07:04 PM
APPLE ROBERT F	President & CEO	Feb 18	Option Exercise	0.88	250,000	220,000	2,696,720	Feb 19 07:11 PM
JACOB LEONARD S	Director	Feb 18	Option Exercise	2.24	15,321	34,319	268,363	Feb 19 07:08 PM
GRAHAM PETER J	EVP General Counsel, Secretary	Feb 18	Option Exercise	1.12	45,000	50,400	585,417	Feb 19 07:07 PM
APPLE ROBERT F	President & CEO	Feb 18	Sale	5.00	491,960	2,459,978	2,204,760	Feb 19 07:11 PM
JACOB LEONARD S	Director	Feb 18	Sale	5.05	15,321	77,371	253,042	Feb 19 07:08 PM
GRAHAM PETER J	EVP General Counsel, Secretary	Feb 18	Sale	4.93	45,000	221,650	540,417	Feb 19 07:07 PM
APPLE ROBERT F	President & CEO	Feb 17	Option Exercise	2.62	5,519	14,460	2,452,239	Feb 19 07:11 PM
APPLE ROBERT F	President & CEO	Feb 17	Sale	4.75	5,519	26,215	2,446,720	Feb 19 07:11 PM
GARRITY THOMAS J	Director	Feb 11	Option Exercise	1.12	50,000	56,000	274,406	Feb 12 06:53 PM
GARRITY THOMAS J	Director	Feb 11	Sale	4.62	50,000	231,000	224,406	Feb 12 06:53 PM
APPLE ROBERT F	President & CEO	Feb 10	Option Exercise	2.62	7,278	19,068	2,302,433	Feb 10 08:11 PM
APPLE ROBERT F	President & CEO	Feb 10	Sale	4.75	7,278	34,570	2,295,155	Feb 10 08:11 PM
APPLE ROBERT F	President & CEO	Feb 09	Option Exercise	2.62	49,129	128,718	2,344,284	Feb 10 08:11 PM
APPLE ROBERT F	President & CEO	Feb 09	Sale	4.75	49,129	233,363	2,295,155	Feb 10 08:11 PM
APPLE ROBERT F	President & CEO	Feb 08	Option Exercise	2.62	33,574	87,964	2,328,729	Feb 10 08:11 PM
APPLE ROBERT F	President & CEO	Feb 08	Sale	4.75	33,574	159,476	2,295,155	Feb 10 08:11 PM
GARRITY THOMAS J	Director	Jan 11	Option Exercise	1.44	70,000	100,800	274,406	Jan 13 08:21 PM
GARRITY THOMAS J	Director	Jan 11	Sale	4.06	70,000	283,900	224,406	Jan 13 08:21 PM
Powell Fred M	Executive Vice President & CFO	Nov 12	Buy	2.85	16,400	46,740	646,465	Nov 16 07:04 AM
GUETH ANTON	Director	May 13	Option Exercise	1.60	72,487	115,979	399,236	May 15 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience